Form D · Venture Capital Fund

Mission BioCapital VI LP

Cambridge, MA · CIK 0002039280

Offering snapshot reported Nov 14, 2025 · SEC filing

Reported sold: $144M
Investors reported: 11
Minimum accepted: $0
First sale: Sep 30, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$133,750,000 → $143,750,000
Reported investors9 → 11

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 14, 2025	Amendment	$143,750,000	$10,000,000vs Sep 26, 2025	11	SEC filing
Sep 26, 2025	Amendment	$133,750,000	No comparison	9	SEC filing
Sep 27, 2024	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $156K
Finders' fees: $0
Form D file number: 021-525216

The Placement Agent's fees are dependent on the capital raised and will be paid by Mission BioCapital Management Company LLC.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
BHA Select Network, LLC	168883

Source: Form D, filed Nov 14, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

MISSION BIOCAPITAL VI LP

Investment adviser: MISSION BIOCAPITAL MANAGEMENT COMPANY LLC

Gross asset value: $154M
Beneficial owners: 15
ADV minimum commitment: $1M

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CARTA INVESTOR SERVICES SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG LLP BOSTON, Massachusetts, United States

Custodian CITIZENS BANK RIVERSIDE, Rhode Island, United States Related to adviser: No

Custodian FIRST CITIZENS BANCSHARES RALEIGH, North Carolina, United States Related to adviser: No

Marketer BHA SELECT NETWORK, LLC BOSTON, Massachusetts, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG LLP
PCAOB 185

BHA SELECT NETWORK, LLC
CRD 168883 · SEC 8-69341

Filing source

Form ADV 2056312 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-9260253600

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
MISSION BIOCAPITAL V LP	Apr 13, 2021	$191,930,000	0
Mission BioCapital VI LP (this fund)	Nov 14, 2025	$143,750,000	11

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
General Partner Mission Bio Capital Vi Gp Llc	Promoter
Peter D. Parker	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

One Main Street, Suite 1100
Cambridge, MA, 02142